US Bancorp’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.5K | Sell |
757
-7,756
| -91% | -$87.1K | ﹤0.01% | 3475 |
|
|
2025
Q1 | $38.9K | Sell |
8,513
-22,103
| -72% | -$101K | ﹤0.01% | 2857 |
|
|
2024
Q4 | $173K | Buy |
30,616
+11,810
| +63% | +$66.6K | ﹤0.01% | 2098 |
|
|
2024
Q3 | $91K | Buy |
18,806
+17,720
| +1,632% | +$85.8K | ﹤0.01% | 2440 |
|
|
2024
Q2 | $5.3K | Buy |
1,086
+760
| +233% | +$3.71K | ﹤0.01% | 3479 |
|
|
2024
Q1 | $4.33K | Hold |
326
| – | – | ﹤0.01% | 3553 |
|
|
2023
Q4 | $4.54K | Sell |
326
-130
| -29% | -$1.81K | ﹤0.01% | 3551 |
|
|
2023
Q3 | $6.05K | Hold |
456
| – | – | ﹤0.01% | 3350 |
|
|
2023
Q2 | $8.55K | Buy |
456
+286
| +168% | +$5.36K | ﹤0.01% | 3291 |
|
|
2023
Q1 | $2.45K | Sell |
170
-27
| -14% | -$389 | ﹤0.01% | 3685 |
|
|
2022
Q4 | $3.81K | Sell |
197
-6,615
| -97% | -$128K | ﹤0.01% | 3591 |
|
|
2022
Q3 | $235K | Buy |
6,812
+6,318
| +1,279% | +$218K | ﹤0.01% | 1766 |
|
|
2022
Q2 | $8K | Buy |
+494
| New | +$8K | ﹤0.01% | 3431 |
|